Work

Brentuximab vedotin with chemotherapy in adolescents and young adults (AYAs) with stage III or IV Hodgkin lymphoma: A subgroup analysis from the phase 3 Echelon-1 study.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.7528

Authors: Howland E. Crosswell, Ann S. LaCasce, Nancy L. Bartlett, David J. Straus, Kerry J. Savage, Pier Luigi Zinzani, Graham P. Collins, Michelle A. Fanale, Keenan Fenton, Cassie Dong, Harry H. Miao, Andrew Grigg

Institutions: Bon Secours Health System, Dana-Farber Cancer Institute, Washington University in St. Louis, Memorial Sloan Kettering Cancer Center, BC Cancer Agency, University of Bologna, Oxford University Hospitals NHS Trust, Seagen (United States), Takeda Oncology (United States), Austin Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3166545929

Cites:

Cited by: 4

Related to: 10